CLINICAL_TRIALS
trial_result
· 2022-05-26
Clinical Trial Update: Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome [Phase 3]
Summary
Phase 3 clinical trial updating the efficacy of ulinastatin for treatment of sepsis with systemic inflammatory response syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Huashan Hospital | Conditions: Sepsis | Phase 3 | Status: UNKNOWN